Literature DB >> 26432068

Experimental Transmission of African Swine Fever (ASF) Low Virulent Isolate NH/P68 by Surviving Pigs.

C Gallardo1, A Soler1, R Nieto1, M A Sánchez1, C Martins2, V Pelayo1, A Carrascosa3, Y Revilla3, A Simón1, V Briones1, J M Sánchez-Vizcaíno4, M Arias1.   

Abstract

African swine fever (ASF) has persisted in Eastern Europe since 2007, and two endemic zones have been identified in the central and southern parts of the Russian Federation. Moderate- to low-virulent ASF virus isolates are known to circulate in endemic ASF-affected regions. To improve our knowledge of virus transmission in animals recovered from ASF virus infection, an experimental in vivo study was carried out. Four domestic pigs were inoculated with the NH/P68 ASF virus, previously characterized to develop a chronic form of ASF. Two additional in-contact pigs were introduced at 72 days post-inoculation (dpi) in the same box for virus exposure. The inoculated pigs developed a mild form of the disease, and the virus was isolated from tissues in the inoculated pigs up to 99 dpi (pigs were euthanized at 36, 65, 99 and 134 dpi). In-contact pigs showed mild or no clinical signs, but did become seropositive, and a transient viraemia was detected at 28 days post-exposure (dpe), thereby confirming late virus transmission from the inoculated pigs. Virus transmission to in-contact pigs occurred at four weeks post-exposure, over three months after the primary infection. These results highlight the potential role of survivor pigs in disease maintenance and dissemination in areas where moderate- to low-virulent viruses may be circulating undetected. This study will help design better and more effective control programmes to fight against this disease.
© 2015 Blackwell Verlag GmbH.

Entities:  

Keywords:  African swine fever; carrier state; virus transmission

Mesh:

Year:  2015        PMID: 26432068     DOI: 10.1111/tbed.12431

Source DB:  PubMed          Journal:  Transbound Emerg Dis        ISSN: 1865-1674            Impact factor:   5.005


  34 in total

1.  Variations in clinical presentation and anatomical distribution of gross lesions of African swine fever in domestic pigs in the southern highlands of Tanzania: a field experience.

Authors:  Maulilio John Kipanyula; Solomon Wilson Nong'ona
Journal:  Trop Anim Health Prod       Date:  2016-12-03       Impact factor: 1.559

2.  African Swine Fever Virus (ASFV) Indirect ELISA Test Based on the Use of the Soluble Cytoplasmic Semi- purified Antigen (ASFV CP-Ag).

Authors:  Gallardo Carmina; R Nieto; M Arias
Journal:  Methods Mol Biol       Date:  2022

3.  The attenuated ASFV strains MK-200 and FK-32/135 as possible models for investigation of protective immunity by ASFV infection.

Authors:  Alexey D Sereda; Anna S Kazakova; Sanzhi G Namsrayn; Mikhail E Vlasov; Denis V Kolbasov
Journal:  PLoS One       Date:  2022-07-07       Impact factor: 3.752

4.  A Cell Culture-Adapted Vaccine Virus against the Current African Swine Fever Virus Pandemic Strain.

Authors:  M V Borca; A Rai; E Ramirez-Medina; E Silva; L Velazquez-Salinas; E Vuono; S Pruitt; N Espinoza; D P Gladue
Journal:  J Virol       Date:  2021-06-24       Impact factor: 5.103

Review 5.  Transmission routes of African swine fever virus to domestic pigs: current knowledge and future research directions.

Authors:  Claire Guinat; Andrey Gogin; Sandra Blome; Guenther Keil; Reiko Pollin; Dirk U Pfeiffer; Linda Dixon
Journal:  Vet Rec       Date:  2016-03-12       Impact factor: 2.695

6.  Evidence for the presence of African swine fever virus in an endemic region of Western Kenya in the absence of any reported outbreak.

Authors:  Lian F Thomas; Richard P Bishop; Cynthia Onzere; Michael T Mcintosh; Karissa A Lemire; William A de Glanville; E Anne J Cook; Eric M Fèvre
Journal:  BMC Vet Res       Date:  2016-09-08       Impact factor: 2.741

7.  Development of a novel lateral flow assay for detection of African swine fever in blood.

Authors:  P Sastre; C Gallardo; A Monedero; T Ruiz; M Arias; A Sanz; P Rueda
Journal:  BMC Vet Res       Date:  2016-09-15       Impact factor: 2.741

8.  Different routes and doses influence protection in pigs immunised with the naturally attenuated African swine fever virus isolate OURT88/3.

Authors:  Pedro J Sánchez-Cordón; Dave Chapman; Tamara Jabbar; Ana L Reis; Lynnette Goatley; Christopher L Netherton; Geraldine Taylor; Maria Montoya; Linda Dixon
Journal:  Antiviral Res       Date:  2016-11-28       Impact factor: 5.970

9.  Evaluation of Lesions and Viral Antigen Distribution in Domestic Pigs Inoculated Intranasally with African Swine Fever Virus Ken05/Tk1 (Genotype X).

Authors:  Pedro J Sánchez-Cordón; Tobias Floyd; Daniel Hicks; Helen R Crooke; Stephen McCleary; Ronan R McCarthy; Rebecca Strong; Linda K Dixon; Aleksija Neimanis; Emil Wikström-Lassa; Dolores Gavier-Widén; Alejandro Núñez
Journal:  Pathogens       Date:  2021-06-18

Review 10.  Approaches and Perspectives for Development of African Swine Fever Virus Vaccines.

Authors:  Marisa Arias; Ana de la Torre; Linda Dixon; Carmina Gallardo; Ferran Jori; Alberto Laddomada; Carlos Martins; R Michael Parkhouse; Yolanda Revilla; Fernando And Jose-Manuel Rodriguez
Journal:  Vaccines (Basel)       Date:  2017-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.